Navigation Links
Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting

New M5 and DC-3 Color Doppler Diagnostic Ultrasound Systems on Display

SHENZHEN, China, Feb. 18 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Jie Liu, Mindray's executive vice president of international sales and marketing, and Mr. Sheng Ma, Mindray's president of international sales and marketing for ultrasound imaging systems, will attend the 2008 European Congress of Radiology to be held March 7 to 11, in Vienna, Austria.

"Our products continue to receive strong brand loyalty, particularly in European markets and we are delighted to showcase our ultrasound imaging systems at such a prominent international event," said Mr. Xu Hang, Mindray's chairman and co-chief executive officer. "Specifically, we are excited to display the M5 and DC-3 that both hold significant market potential. Our high-quality, competitively priced products are the result of our disciplined investment in R&D and ability to tailor products by price and functionality for markets around the world."

The company will exhibit both its new M5, a portable color Doppler diagnostic ultrasound system released in December 2007, and DC-3, a color Doppler diagnostic ultrasound system which will be launched domestically upon receiving SFDA approval and internationally upon receiving CE Mark, which is expected to occur during the first quarter of 2008.

"The M5 is ideally suited for both new and traditional markets such as radiology and OB/GYN as well as Point-of-Care-Testing ("POCT") centers such as emergency and operating rooms, intensive care units and general practice offices," said Mr. Li Xiting, Mindray's president and co-chief executive officer. "The DC-3 is customized for hospitals and clinics looking to replace B&W diagnostic ultrasound systems."

The company will also display its established DC-6, DC-6E, DP-6600, DP-7700, DP-8800 plus, DP-9900 plus, DP-2200, DP-3300, DP-6600 Vet products in Expo E at booth number 540.

Since 2003, Mindray has exported its diagnostic ultrasound systems to more than 140 countries. These systems are employed in medical fields such as urology, gynecology, obstetrics, abdomen, small parts and cardiology.

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Amsterdam, Boston, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit .

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about new product releases and regulatory approvals are forward- looking statements. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public documents filed with the Securities and Exchange Commission. For a discussion of some of the risks and important factors that could affect Mindray's actual results and financial condition, see "Risk Factors" in Part I, Item 3D of Mindray's Annual Report on Form 20-F for the fiscal year ended December 31, 2006 and "Operating and Financial Review and Prospects" in Part I, Item 5 of Mindray's Annual Report on Form 20-F for the fiscal year ended December 31, 2006. Mindray does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release is as of February 18, 2008, and Mindray undertakes no duty to update such information, except as required under applicable law.

For investor and media inquiries please contact:

In China:

Investor Relations

Mindray Medical International Limited

Tel: +86-755-2658-2518


Justin Knapp

Ogilvy Public Relations Worldwide, Beijing

Tel: +86-10-8520-6556


In the United States:

Jeremy Bridgman

Ogilvy Public Relations Worldwide, New York

Tel: +1-212-880-5363

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray to Attend 2008 CLSA Asia Investors Forum
2. Mindray to Attend 2007 RSNA Conference in Chicago
3. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007
4. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
5. Specimens in BODY WORLDS Exhibitions Stem Primarily from German Body Donation Program
6. An Open Letter to 20/20 and the Shareholders of Premier Exhibitions, Inc.
7. Milestone Scientific to Exhibit at the Chicago Dental Societys 143rd Midwinter Meeting
8. On Valentines Day, Abbott Urges Women to Take Heart With Launch of Faces of Heart Disease Exhibit to Raise Heart Health Awareness
9. The Brand Experience Teams With World Vision to Launch Experience: AIDS Multi-Media Exhibit
10. Total Site Solutions to Exhibit at HIMSS Conference
11. The Institute for Plastination Responds to the Bishop of Manchesters Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: